Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Monthly Exercise Status of the 35th Series of Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Terms)

In June 2026, 9,060 of the 35th Stock Acquisition Rights were exercised, and 906,000 new shares were delivered. As of the end of the month, 138,760 rights (13,876,000 shares) remained unexercised.

Worth reading
66In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
906000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Exercise status report for the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

Who receives how much

Number of shares delivered during the relevant month: 906,000 shares (906,000 new shares and 0 treasury shares transferred)

グロース・キャピタル株式会社 (issued on 5 June 2026)

The lower thin line represents the existing number of shares to which these shares will be added.

Existing Shares and Increase
+1.53%Rate of increase
59,365,100 shares60,271,100Shares

Approximately 1.53% based on 906,000 shares delivered during the relevant month and 59,365,100 shares issued and outstanding as of the end of the previous month (exercise ratio subject to exercise restrictions)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
The exercise price during the relevant month was ¥46, ¥48, ¥51 or ¥56 per share. The rights include an exercise price adjustment clause, but the adjustment floor is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 147,820 rights; unexercised as of 5 June 2026: 147,820 rights; unexercised as of the end of June 2026: 138,760 rights
Procedures under the Corporate Code of Conduct
Report on compliance with the exercise restrictions under Article 434 of the Listing Regulations. The exercise ratio subject to exercise restrictions was 1.53%.
Most recent equity financing
Timing 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalExercise status report for the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed ofNumber of shares delivered during the relevant month: 906,000 shares (906,000 new shares and 0 treasury shares transferred)
Intended allotteeグロース・キャピタル株式会社 (issued on 5 June 2026)
Dilution RateApproximately 1.53% based on 906,000 shares delivered during the relevant month and 59,365,100 shares issued and outstanding as of the end of the previous month (exercise ratio subject to exercise restrictions)
Total number of issued shares59,365,100 shares → 60,271,100 shares
Exercise priceThe exercise price during the relevant month was ¥46, ¥48, ¥51 or ¥56 per share. The rights include an exercise price adjustment clause, but the adjustment floor is Not disclosed.
Number of Stock Acquisition RightsTotal issued: 147,820 rights; unexercised as of 5 June 2026: 147,820 rights; unexercised as of the end of June 2026: 138,760 rights
Procedures under the Corporate Code of ConductReport on compliance with the exercise restrictions under Article 434 of the Listing Regulations. The exercise ratio subject to exercise restrictions was 1.53%.
Most recent equity financingTiming 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status of the 35th Stock Acquisition Rights in June 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the 35th Series of Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Terms) | Medrx Co.,Ltd. (4586) timely disclosure | Komori